Egal Pads, Inc, 1 Fitchburg St, Apt C305, Somerville, MA 02143, US

Finch Therapeutics, based in Somerville, MA, is a pioneering company in the field of microbiome therapeutics, with a robust intellectual property estate and a portfolio of innovative microbiome assets. They have recently made the decision to discontinue their Phase 3 trial of CP101 in recurrent C. difficile and focus on realizing the value of their IP estate and other assets. With insights from human microbiota transplantation studies, Finch has established a leading portfolio of microbiome assets that have potential applicability to a wide range of product strategies and therapeutic areas. They are dedicated to advancing the field of microbiome therapeutics and exploring partnership opportunities to further their mission.Generated from the website

Macgregor Graphics

Smith, Adelaide S

Loto Lighting

Pier Gustafson